PTCT
PTC Therapeutics Inc
63.50$
-1.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +56.2% | -31.6% | -11.1% | +5.4% | +8.3% | +451.7% | -84.8% | +18.0% | -22.0% | +65.5% | +32.3% | – | |
| – | +1,019.7% | -86.1% | +5.3% | -30.1% | +50.1% | -21.0% | -11.2% | +915.2% | -85.9% | +72.0% | -28.9% | – | |
| – | +7.3% | -2.7% | -12.4% | +8.6% | +5.9% | +490.8% | -85.6% | -43.2% | +56.1% | +64.8% | +39.3% | – | |
| – | -26.1% | -4.3% | +13.8% | +22.1% | -22.7% | -12.7% | +3.7% | -11.4% | +32.9% | -24.2% | -1.7% | – | |
| – | +0.0% | -9.4% | -5.1% | +5.7% | +15.3% | -4.4% | +5.3% | -1.4% | +15.3% | -11.0% | -6.4% | – | |
| – | -35.3% | +21.9% | -12.2% | +13.7% | +49.4% | -46.3% | +4.9% | -54.5% | +149.9% | -13.6% | -3.5% | – | |
| – | – | -1,556.8% | – | – | – | – | -103.6% | – | -2,806.4% | – | +224.7% | – | |
| – | +57.2% | -7.8% | +6.5% | -4.3% | -1.3% | -17.0% | -11.0% | +7.4% | +69.3% | -11.2% | -1.1% | – | |
| – | – | – | – | – | – | – | -107.6% | – | – | – | – | – | |
| – | – | – | +95.4% | -35.6% | -432.6% | – | -109.8% | – | – | – | +3,948.7% | – | |
| – | – | – | – | – | – | – | -107.5% | – | -949.1% | – | – | – | |
| – | – | – | -405.4% | – | – | – | -103.4% | – | -444.2% | – | +161.2% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.